Pseudomonas aeruginosa exoproteins, for example, have been shown to disrupt mucosal barriers and increase IL-6 production in asthmatic patients with chronic rhinosinusitis, potentially contributing to mucosal inflammation and exacerbating asthma symptoms (Tuli et al., 2021). The gene discussed is IL6; the disease is chronic rhinosinusitis.